
Experience with the administration of high doses of zzso 2 zzso alone is described zzso Ten patients with a variety of zzso disorders unresponsive to conventional treatments were treated with at least 30,000 zzso of zzso by zzso administration three times a zzso Patients were treated zzso or zzso from four to 21 days in a single course, usually interrupted by a week of zzso Three of six patients with melanoma experienced an objective zzso zzso than 50% decrease in zzso there was no response to treatment in patients with zzso zzso or zzso zzso zzso Two patients with initial objective zzso who subsequently developed progression were zzso and one sustained a second partial zzso zzso lasted 1, 3, and 7 months without additional zzso zzso in the three patients with melanoma were in visceral sites zzso liver, and zzso as well as zzso sites in one zzso Progressive shrinkage of tumors for three to six months after the conclusion of therapy has been noted in two zzso zzso zzso zzso was noted in a patient with zzso accessible to repeated zzso This study demonstrates that the administration of zzso can mediate the zzso of established cancer in some zzso 

